And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

Thilo Schroeder Biography and Net Worth

Director of PMV Pharmaceuticals

Thilo Schroeder, Ph.D. is a Partner at Nextech and has a passion for precision medicines in cancer with a focus on identifying first and best-in-class targeted therapies regardless of drug modality.

Thilo is a board member of Revolution Medicines, PMV Pharma, IDEAYA Biosciences (NASDAQ: IDYA), ImaginAb and is a board observer of Black Diamond Therapeutics. Past board seats include Blueprint Medicines (NASDAQ: BPMC) and Peloton Therapeutics (acquired by Merck).

Thilo began his biotech career at the pioneering cancer immunology company Micromet (acquired by Amgen) while studying at Ecole Supérieure de Biotechnologie de Strasbourg, conducted research at the University of Sydney and obtained his Ph.D. from the University of Zurich, focused on protein engineering in the development of Designed Ankyrin Repeat Proteins (DARPins), a technology developed by Molecular Partners (SWX:MOLN).

What is Thilo Schroeder's net worth?: The estimated net worth of Thilo Schroeder is at least $2.50 million as of March 10th, 2023. Mr. Schroeder owns 1,553,134 shares of PMV Pharmaceuticals stock worth more than $2,500,546 as of April 20th. This net worth estimate does not reflect any other assets that Mr. Schroeder may own. Learn More about Thilo Schroeder's net worth.
How do I contact Thilo Schroeder?: The corporate mailing address for Mr. Schroeder and other PMV Pharmaceuticals executives is , , . PMV Pharmaceuticals can also be reached via phone at 609-642-6670 and via email at [email protected]. Learn More on Thilo Schroeder's contact information.
Has Thilo Schroeder been buying or selling shares of PMV Pharmaceuticals?: Thilo Schroeder has not been actively trading shares of PMV Pharmaceuticals during the last quarter. Most recently, Thilo Schroeder sold 800 shares of the business's stock in a transaction on Wednesday, October 6th. The shares were sold at an average price of $30.15, for a transaction totalling $24,120.00. Learn More on Thilo Schroeder's trading history.
Who are PMV Pharmaceuticals' active insiders?: PMV Pharmaceuticals' insider roster includes Leila Alland (Insider), Richard Heyman (Director), Winston Kung (CFO), Arnold Levine (Director), David Mack (CEO), and Thilo Schroeder (Director). Learn More on PMV Pharmaceuticals' active insiders.
Are insiders buying or selling shares of PMV Pharmaceuticals?: During the last twelve months, insiders at the sold shares 2 times. They sold a total of 91,890 shares worth more than $222,931.26. The most recent insider tranaction occured on November, 22nd when Major Shareholder Orbimed Advisors Llc sold 87,786 shares worth more than $195,762.78. Insiders at PMV Pharmaceuticals own 7.6% of the company. Learn More about insider trades at PMV Pharmaceuticals.
Information on this page was last updated on 11/22/2023.

Thilo Schroeder Insider Trading History at PMV Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
10/6/2021	Sell	800	$30.15	$24,120.00
10/4/2021	Sell	100	$30.08	$3,008.00
10/1/2021	Sell	11,541	$30.10	$347,384.10
9/29/2021	Sell	5,708	$30.04	$171,468.32
9/27/2021	Sell	1,753	$30.11	$52,782.83
9/17/2021	Sell	711	$30.03	$21,351.33
9/13/2021	Sell	13,272	$30.20	$400,814.40
9/9/2021	Sell	14,329	$30.31	$434,311.99
9/1/2021	Sell	21,986	$30.38	$667,934.68
8/30/2021	Sell	13,233	$30.05	$397,651.65
8/27/2021	Sell	24,442	$30.52	$745,969.84
8/25/2021	Sell	13,526	$31.01	$419,441.26
8/18/2021	Sell	26,864	$33.34	$895,645.76
8/16/2021	Sell	22,183	$33.89	$751,781.87
8/13/2021	Sell	27,286	$34.24	$934,272.64
8/11/2021	Sell	34,439	$34.04	$1,172,303.56
8/9/2021	Sell	22,182	$35.53	$788,126.46
8/6/2021	Sell	19,900	$36.61	$728,539.00
8/4/2021	Sell	52,860	$35.85	$1,895,031.00
8/2/2021	Sell	13,031	$34.74	$452,696.94
7/28/2021	Sell	8,724	$35.76	$311,970.24
7/26/2021	Sell	4,839	$35.73	$172,897.47
7/22/2021	Sell	200	$35.61	$7,122.00
5/28/2021	Sell	5,100	$35.80	$182,580.00
5/26/2021	Sell	7,487	$35.66	$266,986.42
5/24/2021	Sell	22,095	$36.03	$796,082.85
5/10/2021	Sell	1,787	$35.67	$63,742.29
5/5/2021	Sell	600	$35.64	$21,384.00
4/12/2021	Sell	3,903	$31.41	$122,593.23
4/8/2021	Sell	136,436	$34.31	$4,681,119.16
4/5/2021	Sell	48,193	$33.81	$1,629,405.33
3/31/2021	Sell	33,626	$32.52	$1,093,517.52
3/29/2021	Sell	2,174	$32.15	$69,894.10
3/26/2021	Sell	35,268	$33.44	$1,179,361.92
3/24/2021	Sell	34,881	$36.50	$1,273,156.50

Thilo Schroeder Buying and Selling Activity at PMV Pharmaceuticals

PMV Pharmaceuticals Company Overview

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.

Today's Range

Now: $1.61

$1.58

$1.66

50 Day Range

MA: $1.68

$1.51

$1.93

2 Week Range

Now: $1.61

$1.18

$9.72

Volume

479,632 shs

Average Volume

524,410 shs

Market Capitalization

$82.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.65

Did You Get Your Free Bitcoin Yet?

From Crypto Swap Profits | Ad

>> Register right here